Local Institution - 106

New York, New York 10065

0 studies enrolling now · 4 studies all time

What they study most

Leukemia, Myeloid, Acute, Multiple Myeloma, Neoplasms

Studies at this site

• A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy — Running, not enrolling
• A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers — Completed
• A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma — Stopped early
• A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML) — Completed